US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 122.820
- +0.020+0.02%
Close Oct 31 16:00 ET
- 122.820
- 0.0000.00%
Post 16:03 ET
7.34BMarket Cap-13124P/E (TTM)
124.660High120.770Low344.93KVolume121.400Open122.800Pre Close42.40MTurnover0.58%Turnover RatioLossP/E (Static)59.76MShares161.00052wk High-21.05P/B7.29BFloat Cap86.54552wk Low--Dividend TTM59.32MShs Float183.980Historical High--Div YieldTTM3.17%Amplitude11.920Historical Low122.935Avg Price1Lot Size
About Ascendis Pharma A/S Company
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
Company Profile
SymbolASND
Company NameAscendis Pharma A/S
Listing DateJan 28, 2015
Issue Price18.00
Founded2006
CEOMr. Jan Moller Mikkelsen
MarketNASDAQ
Employees879
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressTuborg Boulevard 12
CityHellerup
ProvinceCapital Region
CountryDenmark
Zip Code2900
Phone45-70-22-22-44
Company Executives
- Name
- Position
- Salary
- Jan Moller Mikkelsen
- President, Chief Executive Officer and Director
- --
- Camilla Harder Hartvig
- Executive Vice President and Global Chief Commercial Officer
- --
- Scott T Smith
- Executive Vice President and Chief Financial Officer
- --
- Michael Wolff Jensen
- Executive Vice President and Chief Legal Officer
- --
- Lotte Sonderbjerg
- Executive Vice President and Chief Administrative Officer
- --
- Peter Rasmussen
- Vice President, Finance and Principal Accounting Officer
- --
- Dr. Kennett Sprogoe, PhD
- Executive Vice President and Head of Innovation and Research
- --
- Dr. Stina Singel, M.D.
- Executive Vice President and Head of Clinical Development, Oncology
- --
- Flemming Steen Jensen
- Executive Vice President, Product Supply and Quality
- --
- Dr. Albert Cha, M.D.,PhD
- Chairman of the Board
- --
- Lars Holtug
- Independent Director
- --
- Lisa Bright
- Independent Director
- --
- William Carl Fairey
- Independent Director
- --
- Siham Imani
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data